Advise Digital Health and Health-Tech Startups as a Physician

Digital health advisory is clinical guidance for companies building health technology: telehealth platforms, clinical software, AI tools, care-delivery models, and devices. As an advisor, fractional chief medical officer, or advisory board member, you tell founders how care really works, whether a product fits clinical reality, what regulatory and safety considerations apply, and how clinicians will adopt it. Compensation is often a blend of cash fees and equity, especially for early-stage startups. It is non-clinical income built on clinical expertise and workflow knowledge, and because it is a fast-growing field, demand for credible physician advisors is strong. The equity component adds upside and risk that you have to understand to value the role.

Health-tech founders are frequently technologists or operators who do not know how clinical care is actually delivered, and building the wrong thing is fatal in a regulated, safety-critical market. A physician who has lived the workflow can prevent expensive mistakes, open clinical doors, and lend credibility to the product, which is why startups pay in cash, equity, or both for that input. The field is growing fast, so demand for credible clinical advisors is rising. For the physician, it is flexible, remote-friendly, and layered on top of clinical work, with equity offering upside that a salaried role never does, though that upside is uncertain. The scarcity of physicians who understand both medicine and how startups work is what makes credible advisors valuable.

Physicians pass on advisory roles for two reasons. First, they experience their workflow knowledge as ordinary rather than as a scarce input a startup desperately needs, so requests for their time read as favors rather than paid roles. Second, equity compensation is genuinely unfamiliar: doctors are not trained to value equity, negotiate advisory shares, or weigh the risk, so an offer that is partly equity feels confusing and easy to undervalue or decline. The combination leaves a fast-growing, well-compensated category under-pursued by the very clinicians startups most want, and captured by the smaller number of physicians who learned enough about startups and equity to say yes on good terms.